Market revenue in 2023 | USD 62.0 million |
Market revenue in 2030 | USD 94.8 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Sequencing by synthesis |
Fastest growing segment | Sequencing by synthesis |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequencing by synthesis, Sequencing by ligation, Sanger sequencing |
Key market players worldwide | Microbiome Insights Inc., BaseClear, Clinical Microbiomics, Mérieux NutriSciences Corporation, Mr Dna, Metabiomics, Rancho BioSciences, Second Genome, Zymo Research, uBiome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbiome sequencing services market will help companies and investors design strategic landscapes.
Sequencing by synthesis was the largest segment with a revenue share of 59.52% in 2023. Horizon Databook has segmented the Middle East & Africa microbiome sequencing services market based on sequencing by synthesis, sequencing by ligation, sanger sequencing covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East and Africa are witnessing a lucrative demand for microbiome sequencing services due to their potential to revolutionize healthcare. These regions are home to diverse populations with unique genetic backgrounds and lifestyles, contributing to distinct microbiome compositions.
Microbiome sequencing offers insights into various health conditions, from gastrointestinal disorders to autoimmune diseases. As awareness grows about the microbiome's role in overall well-being, clinicians, researchers, and pharmaceutical companies are increasingly seeking these services.
Moreover, governments are investing in cutting-edge biotechnology to enhance medical diagnostics and therapeutics. This escalating demand underscores the pivotal role of microbiome sequencing in advancing personalized medicine and public health.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa microbiome sequencing services market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa microbiome sequencing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account